Brusatol: A potential sensitizing agent for cancer therapy from Brucea java']javanica

被引:18
作者
He, Ting [1 ,2 ]
Zhou, Fangli [3 ]
Su, Anping [1 ,2 ]
Zhang, Yujie [1 ,2 ]
Xing, Zhichao [1 ,2 ]
Mi, Li [1 ,2 ]
Li, Zhihui [1 ,2 ]
Wu, Wenshuang [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thyroid Surg, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Frontiers Sci Ctr Dis Related Mol Network, Lab Thyroid & Parathyroid Dis, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Brusatol; Nrf2; inhibitor; Apoptosis; Synergistic antitumor effect; Molecular mechanism; COLORECTAL-CANCER; UP-REGULATION; INHIBITION; NRF2; CELLS; RESISTANCE; APOPTOSIS; PATHWAY; AUTOPHAGY; TOXICITY;
D O I
10.1016/j.biopha.2022.114134
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer is currently the most important problem endangering human health. As antitumor drugs have always been the most common methods for treating cancers, searching for new antitumor agents is of great significance. Brusatol, a quassinoid from the seeds of Brucea javanica, exhibits a potent tumor-suppressing effect with improved disease outcome. Studies have shown that brusatol not only shows potential tumor inhibition through multiple pharmacological effects, such as promoting apoptosis and inhibiting metastasis but also exhibits sig-nificant synergistic antitumor effects in combination with chemotherapeutic agents and overcoming chemical resistance in a wide range of cancer types. In this paper, the antitumor effects and mechanisms of brusatol were reviewed to provide evidence that brusatol has the exact antitumor efficacy of chemotherapeutic agents and show the potential of brusatol to be developed as a promising antitumor drug.
引用
收藏
页数:9
相关论文
共 71 条
  • [1] Potential cancer treatment effects of brusatol or eriodictyol combined with 5-fluorouracil (5-FU) in colorectal cancer cell
    Ardil, Buse
    Alper, Mehlika
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (09) : 1109 - 1123
  • [2] The apoptotic effects of Brucea java']javanica fruit extract against HT29 cells associated with p53 upregulation and inhibition of NF-κB translocation
    Bagheri, Elham
    Hajiaghaalipour, Fatemeh
    Nyamathulla, Shaik
    Salehen, Nur'Ain
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 657 - 671
  • [3] Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo
    Bovilla, Venugopal R.
    Kuruburu, Mahadevaswamy G.
    Bettada, Vidya G.
    Krishnamurthy, Jayashree
    Sukocheva, Olga A.
    Thimmulappa, Rajesh K.
    Shivananju, Nanjunda Swamy
    Balakrishna, Janardhan P.
    Madhunapantula, SubbaRao, V
    [J]. BIOMEDICINES, 2021, 9 (09)
  • [4] [Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]
  • [5] Brusatol, an NRF2 inhibitor for future cancer therapeutic
    Cai, Sabrina J.
    Liu, Yang
    Han, Sue
    Yang, Chunzhang
    [J]. CELL AND BIOSCIENCE, 2019, 9 (1)
  • [6] An in vitro study on the reversal of epithelial to mesenchymal transition by brusatol and its synergistic properties in triple-negative breast cancer cells
    Chandrasekaran, Jaikanth
    Balasubramaniam, Jayasudha
    Sellamuthu, Arunkumar
    Ravi, Aarthi
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2021, 73 (06) : 749 - 757
  • [7] Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells
    Chen, Hai-Ming
    Lai, Zheng-Quan
    Liao, Hui-Jun
    Xie, Jian-Hui
    Xian, Yan-Fang
    Chen, Yun-Long
    Ip, Siu-Po
    Lin, Zhi-Xiu
    Su, Zi-Ren
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (03) : 1447 - 1454
  • [8] NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
    Chio, Iok In Christine
    Jafarnejad, Seyed Mehdi
    Ponz-Sarvise, Mariano
    Park, Youngkyu
    Rivera, Keith
    Palm, Wilhelm
    Wilson, John
    Sangar, Vineet
    Hao, Yuan
    Oehlund, Daniel
    Wright, Kevin
    Filippini, Dea
    Lee, Eun Jung
    Da Silva, Brandon
    Schoepfer, Christina
    Wilkinson, John Erby
    Buscaglia, Jonathan M.
    DeNicola, Gina M.
    Tiriac, Herve
    Hammell, Molly
    Crawford, Howard C.
    Schmidt, Edward E.
    Thompson, Craig B.
    Pappin, Darryl J.
    Sonenberg, Nahum
    Tuveson, David A.
    [J]. CELL, 2016, 166 (04) : 963 - 976
  • [9] Evaluation of efficacy and safety for Brucea java']javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion
    Dai Fuhong
    Gao Xiang
    Li Haiying
    Wang Jiangye
    Gao Xueming
    Chai Wenxiao
    [J]. BMC CANCER, 2018, 18
  • [10] Hypoxia-inducible factor 1:: regulation by hypoxic and non-hypoxic activators
    Déry, MAC
    Michaud, MD
    Richard, DE
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (03) : 535 - 540